BlueBee (@bluebeegenomics) 's Twitter Profile
BlueBee

@bluebeegenomics

High Performance Genomics

ID: 2364457196

linkhttp://www.bluebee.com calendar_today27-02-2014 17:22:56

2,2K Tweet

864 Followers

791 Following

Polaris Genomics (@polarisgenomics) 's Twitter Profile Photo

June is #PTSDAwarenessMonth. At TruGenomix, our year-round mission is to save lives, reduce suffering & eradicate stigma from #PTSD through earlier & more effective diagnosis & treatment of PTSD. trugenomix.com #PTSDAwareness #MentalHealth #BehavioralHealth

June is #PTSDAwarenessMonth. At TruGenomix, our year-round mission is to save lives, reduce suffering & eradicate stigma from #PTSD through earlier & more effective diagnosis & treatment of PTSD. trugenomix.com
#PTSDAwareness #MentalHealth #BehavioralHealth
Front Line Genomics (@flgenomics) 's Twitter Profile Photo

Choosing the right technology for your precision medicine trial is crucial as you consider cost and the wealth of information. An evaluation of WGS, WES & panel sequencing with a focus on oncology can be found here: ow.ly/cveu50A1t1p #Genetics #Genomics #ClinicalTrials

BlueBee (@bluebeegenomics) 's Twitter Profile Photo

Join for RNA NGS! One more day to register - for current users of Lexogen pipelines powered by BlueBee or those who are completely new to #RNAseq & #data analysis. Tomorrow June 9 at 8 am PT | 11 pm ET | 5 pm CEST Register: bluebee.lpages.co/lexogen-websol… #transcriptome #NGS #RNA

Join for RNA NGS! One more day to register - for current users of <a href="/lexogen/">Lexogen</a> pipelines powered by BlueBee or those who are completely new to #RNAseq &amp; #data analysis.

Tomorrow June 9 at 8 am PT | 11 pm ET | 5 pm CEST
Register: bluebee.lpages.co/lexogen-websol…

#transcriptome #NGS #RNA
Polaris Genomics (@polarisgenomics) 's Twitter Profile Photo

As an Illumina Accelerator company led by African American founders, TruGenomix appreciates Illumina CEO, Francis deSouza’s public acknowledgment of our nation’s struggles with racial inequalities. #BlackLivesMatter linkedin.com/pulse/every-vo…

As an <a href="/illumina/">Illumina</a> Accelerator company led by African American founders, TruGenomix appreciates Illumina CEO, <a href="/fdesouza/">Francis deSouza</a>’s public acknowledgment of our nation’s struggles with racial inequalities. #BlackLivesMatter linkedin.com/pulse/every-vo…
BlueBee (@bluebeegenomics) 's Twitter Profile Photo

Register now for #RNASeq applications and technology overview webinar by Lexogen in less than 1.5hr! Registrants will receive the recording to watch on demand. Join Dr. Lauren Sheehan of Lexogen, et al!

Register now for #RNASeq applications and technology overview webinar by <a href="/lexogen/">Lexogen</a> in less than 1.5hr! Registrants will receive the recording to watch on demand. Join Dr. Lauren Sheehan of Lexogen, et al!
Polaris Genomics (@polarisgenomics) 's Twitter Profile Photo

Meet Siren, a US Air Force Fighter Pilot. This PTSD Awareness Month, we're proud to launch TruStories by TruGenomix: An Interview Series Shedding Light on PTSD as Told by Survivors. Here's Siren's Story: trugenomix.com/sirens-story/ #PTSD #PTSDAwareness #PTSDAwarenessMonth

Meet Siren, a US Air Force Fighter Pilot. This PTSD Awareness Month, we're proud to launch TruStories by TruGenomix: An Interview Series Shedding Light on PTSD as Told by Survivors. Here's Siren's Story: trugenomix.com/sirens-story/

#PTSD #PTSDAwareness #PTSDAwarenessMonth
BlueBee (@bluebeegenomics) 's Twitter Profile Photo

Scientists based in Italy studying the #exomes of patients with #COVID19 identified links between genetic and molecular markers and susceptibility to infection, as well as disease severity. clinicalomics.com/topics/patient…

BlueBee (@bluebeegenomics) 's Twitter Profile Photo

In a #GWAS study, variants in both the ABO blood group locus and a cluster of genes on human chromosome 3 are more common among #COVID19 patients with respiratory failure than in the general population. the-scientist.com/news-opinion/t… #coronavirus #genomics #precisionmedicine

BlueBee (@bluebeegenomics) 's Twitter Profile Photo

An important read from Military.com featuring CEO Charles Cathlin of @TruGenomixInc, a powered by BlueBee partner. #Genomics #behavioralhealth #precisionmedicine #PTSD

BlueBee (@bluebeegenomics) 's Twitter Profile Photo

Reserve your spot for next Tuesday’s webinar: The Scientific Informatics of Biology in Bio-pharma and Bio-materials. The focus will be on foundational #informatics tools needed in biological drug and material discovery today. us02web.zoom.us/webinar/regist… #pharma #drugdiscovery

BlueBee (@bluebeegenomics) 's Twitter Profile Photo

Join us in 1 hour! Webinar: The Scientific Informatics of Biology in Bio-pharma and Bio-materials us02web.zoom.us/webinar/regist… #pharma #drugdiscovery #dataanalysis #informatics

BlueBee (@bluebeegenomics) 's Twitter Profile Photo

#LiquidBiopsy with confirmatory PET-CT used to diagnose 26 women with local, regional, or stage 1 cancers and begin treatment in early stages when it is most effective. jamanetwork.com/journals/jama/…

BlueBee (@bluebeegenomics) 's Twitter Profile Photo

Together with @Illumina we will merge high power computing and advanced data science technologies to help propel genomics forward and deliver on its clinical promise.

Agendia (@agendia) 's Twitter Profile Photo

We are thrilled by Illumina’s partnership with BlueBee and look forward to accelerating growth and helping #breastcancer patients by streamlining workflow and using the best in class cloud-computing provider to ensure accurate and timely testing. ow.ly/pHpN50AaMmp

We are thrilled by <a href="/illumina/">Illumina</a>’s partnership with <a href="/BlueBeeGenomics/">BlueBee</a> and look forward to accelerating growth and helping #breastcancer patients by streamlining workflow and using the best in class cloud-computing provider to ensure accurate and timely testing. ow.ly/pHpN50AaMmp
Agendia (@agendia) 's Twitter Profile Photo

MammaPrint + BluePrint together can help empower #breastcancer patients to make informed decisions by determining which patients may benefit from neoadjuvant therapy and those who are better served by going straight to surgery. Learn more here: ow.ly/BubF50AnpVs

MammaPrint + BluePrint together can help empower #breastcancer patients to make informed decisions by determining which patients may benefit from neoadjuvant therapy and those who are better served by going straight to surgery. Learn more here:  ow.ly/BubF50AnpVs
Susan Tousi (@susantousi) 's Twitter Profile Photo

I’m thrilled to welcome Enancio. Together our technologies will offer optimal levels of speed and efficiency for the compression of genomic data, while complementing Illumina’s other informatics solutions.